Alpha Family Trust’s Gilead Sciences GILD Stock Holding History

Alpha Family Trust’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.2M	Hold	8,605	–	–	0.58%	29
2025 Q4	$1.06M	Hold	8,605	–	–	0.48%	33
2025 Q3	$955K	Hold	8,605	–	–	0.45%	40
2025 Q2	$954K	Hold	8,605	–	–	0.47%	38
2025 Q1	$964K	Hold	8,605	–	–	0.56%	35
2024 Q4	$795K	Hold	8,605	–	–	0.45%	34
2024 Q3	$721K	Sell	8,605 -710	-8%	-$54.2K	0.4%	44
2024 Q2	$639K	Buy	9,315 +2,060	+28%	+$137K	0.37%	50
2024 Q1	$531K	Buy	7,255 +710	+11%	+$54.6K	0.32%	59
2023 Q4	$530K	Hold	6,545	–	–	0.36%	51
2023 Q3	$490K	Hold	6,545	–	–	0.37%	53
2023 Q2	$504K	Sell	6,545 -1,670	-20%	-$133K	0.35%	47
2023 Q1	$682K	Buy	8,215 +780	+10%	+$64.6K	0.54%	34
2022 Q4	$638K	Buy	+7,435	New	+$589K	0.58%	35

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Alpha Family Trust's GILD Position: Q1 2026 in Review

Alpha Family Trust held its Gilead Sciences (GILD) position steady in Q1 2026 at 8,605 shares worth $1.2M. The position accounts for 0.58% of the portfolio, ranked #29.

Alpha Family Trust first reported a position in GILD in Q4 2022 and has held it in 14 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Alpha Family Trust held 8,605 shares of Gilead Sciences worth $1.2M as of Q1 2026.
Alpha Family Trust left its Gilead Sciences share count unchanged in Q1 2026.
Gilead Sciences made up 0.58% of Alpha Family Trust's portfolio in Q1 2026, its #29 holding.
Alpha Family Trust first reported a position in Gilead Sciences in Q4 2022 and has held it in 14 quarters since.
2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Alpha Family Trust's 13F filing for Q1 2026, filed 13 May 2026.